Podcasts about gainor

Laura Gainor’s background in pickleball is significant, as she was around the sport in some of its earlier days before it became a national phenomenon. During her time in marketing at USA Pickleball, she witnessed first-hand how the sport was taking off. Today, of course, the numbers speak for themselves. In last year’s Topline Participation Report produced by the Sports & Fitness Industry Association, the group’s researchers reported that pickleball grew 58 percent in participation in the previous year. And over the past three years, that participation has grown by some 223 percent. As a result, brands are looking to get involved with the sport any way they can and event organizers are searching for ways to activate a pickleball experience around their events as well. And development is coming in, too. Entire communities around the country are being planned with pickleball courts in mind to allow people more access to play. Gainor saw the writing on the wall for all these trends and launched Pickleball in the Sun as a way to help brands, event organizers and others navigate the fast-evolving world of pickleball. In this conversation, we discuss how those brands look different today, what you should know about including pickleball as a component of your event, where the sport is going and what, if anything, may slow its momentum.See omnystudio.com/listener for privacy information.

Lindsay Gainor started her journey as the Vice President of Human Resources and Talent Management for ServiceMaster Brands in late April of 2024. Gainor is the head of HR for TWO MEN AND A TRUCK®, TWO MEN AND A JUNK TRUCK®, and Merry Maids®. In addition, Gainor is tasked with building out talent management, which […]

Lindsay Gainor started her journey as the Vice President of Human Resources and Talent Management for ServiceMaster Brands in late April of 2024. Gainor is the head of HR for TWO MEN AND A TRUCK®, TWO MEN AND A JUNK TRUCK®, and Merry Maids®. In addition, Gainor is tasked with building out talent management, which […] The post Lindsay Gainor with Two Men and a Truck appeared first on Business RadioX ®.

Topic: Teamwork Online Webinar Series Ep 13, Tangential Industry Opportunities Guests: Gregg Clifton, Brian Gainor, Carrie Gamper & Mark Dvoroznak

Jeffrey Mosher welcomes Lindsay Gainor, VP of HR and Talent Management, TWO MEN AND A TRUCK, Lansing, MI. Lindsay Gainor started as the new Vice President of Human Resources & Talent Management for ServiceMaster Brands in late April of 2024. There were several things Jeffrey wanted to find out in this conversation: Lindsay, can you discuss your role and your plans? Can you start off by telling us about TWO MEN AND A TRUCK®? What type of positions are TWO MEN AND A TRUCK franchises typically hiring for and what do you look for in candidates? What does career growth look like at TWO MEN AND A TRUCK? To help with hiring TWO MEN AND A TRUCK runs Career Move Season before the busy summer moving months kick off. Can you discuss what Career Move Season is and the success you had this year with it? » Visit MBN website: www.michiganbusinessnetwork.com/ » Watch MBN's YouTube: www.youtube.com/@MichiganbusinessnetworkMBN » Like MBN: www.facebook.com/mibiznetwork » Follow MBN: twitter.com/MIBizNetwork/ » MBN Instagram: www.instagram.com/mibiznetwork/

Mike Gainor, Carolina Handling (Executive Perspective, Episode 11) Executive Perspective host Danny Vander Maten welcomed Mike Gaynor to discuss his work at Carolina Handling. The discussion covered Gaynor’s career journey from Auburn University to leading sales and marketing at Carolina Handling, a company specializing in warehouse automation and material handling solutions. They delved into the […]

Missionary and Revelation Wellness Ambassador, Brandy Gainor, is sitting down with Alisa to share how God is moving to the ends of the earth! With a heart for sharing the gospel, you'll hear how fitness is a tool for Brandy to share the love of Jesus in communities worldwide—from India to England.  Click here to learn more about Brandy and her ministry, Fitness For the Field. Please consider coming on mission with us! Your generosity supports the work of Brandy and over 120 Revelation Ambassadors all over the world. Become a Revelation Wellness Donor today! Click here or text RWDONATE to 801801.  While we're on break next week on the Revelation Wellness Podcast, here are some great episodes to keep you company! #853 REVING the Word "A Great Light" #754 Be Still and Be Loved "A Christmas Edition" #753 REVING the Word "Christmas Weakness is God's Way In" #638 REVING the Word "I Wonder" We love our Rev community and think you will, too! Be sure to get connected with us at: The Official Revelation Wellness Facebook / Instagram / RevWell TV / Youtube   Your reviews matter to us and help spread the good news, so please leave us one where you listen to your podcast! If we read your review on our show, we'll send you a gift from the Revelation Wellness Store!   We'd also love to hear from you! So please leave us a VOICE MESSAGE here!  Tell us what you thought about this episode!  

Missionary and Revelation Wellness Ambassador, Brandy Gainor, is sitting down with Alisa to share how God is moving to the ends of the earth! With a heart for sharing the gospel, you'll hear how fitness is a tool for Brandy to share the love of Jesus in communities worldwide—from India to England.  Click here to learn more about Brandy and her ministry, Fitness For the Field. Please consider coming on mission with us! Your generosity supports the work of Brandy and over 120 Revelation Ambassadors all over the world. Become a Revelation Wellness Donor today! Click here or text RWDONATE to 801801.  While we're on break next week on the Revelation Wellness Podcast, here are some great episodes to keep you company! #853 REVING the Word "A Great Light" #754 Be Still and Be Loved "A Christmas Edition" #753 REVING the Word "Christmas Weakness is God's Way In" #638 REVING the Word "I Wonder" We love our Rev community and think you will, too! Be sure to get connected with us at: The Official Revelation Wellness Facebook / Instagram / RevWell TV / Youtube   Your reviews matter to us and help spread the good news, so please leave us one where you listen to your podcast! If we read your review on our show, we'll send you a gift from the Revelation Wellness Store!   We'd also love to hear from you! So please leave us a VOICE MESSAGE here!  Tell us what you thought about this episode!  

In this episode, we learn the importance of cleansing and detoxing in laying the groundwork for ideal nutrition and maximum health. Explore the wisdom of the four natural laws of healing to overcome health obstacles and realize the potential that lies inside your body.In addition to highlighting the life-changing advantages of the Far Infrared Richway Biomat—a ground-breaking device that improves cardiovascular health, the immune system, and may even help prevent cancer— also discusses personal victories. This is an investment in your wellbeing, not just a retreat.Take advantage of this once-in-a-lifetime chance to improve your healing process by saving money on the revolutionary Far Infrared Richway Biomat and the other equipment indicated.  The important function of the Whole Body Vibration TZone Machine. L. bone on bone. Sharon Walkerhttps://youtu.be/jHeMERIwZ-0?si=vE95yokNPtoQR58Dr Gainorhttps://youtu.be/K1hD50AE8VA?si=8Wr9VyTKA8j4juU8--Demonstrating TZonehttps://youtu.be/kidYZ2njcus?si=uk_yZhpkDLlILhS9https://youtu.be/o36PSGMXFR8?si=hVl3J7v7Q4zz7_ZMComparison between the portable device and the full-size machinehttps://youtu.be/IsagPVz9TxY?si=vmD2CG1tZOsAGwODDr. Gainor Balance Problem. Using TZone to correct balance problems https://youtu.be/k1Lzryq764c?si=HL8u1RuZRxFetEWnChiropractic and Tzone.   Dr Gainor.https://youtu.be/1k4dryPfqS4?si=Vd1t3MufFJTfOMq-Client talks about the TZone experiencehttps://youtu.be/HEbRrOG4W-A?si=InP3YdfHAN7kyr5KThe full Biomat videohttps://youtu.be/_0HR0kJ_50M?si=ysTufr4tJrxFiVeEBiomat Testimonial. https://youtu.be/F6E2nEYn4-8?si=7tFsZmS9-fyP8p3Yhttps://youtu.be/8rvGZFc2F9s?si=fb2SxZzjzxPfr_mFSupport the showReady for your healing journey?Visit our website: www.LivingWatersCleanse.com Or, give us a call at: (208) 378-9911Stem Cell Activation Patches:www.StemCellPatch.netGet your supplements and purifiers here:www.livingwaterscleanse.com/supplementsFollow us on our socials:Facebook: www.facebook.com/livingwaterswellnessInstagram: www.instagram.com/livingwaterswellness YouTube: www.youtube.com/livingwaterswellnesscenterBitChute: www.bitchute.com/livingwaterswellnessRumble: www.rumble.com/livingwatersIf you like this show, support us!Buy Me A Coffee: buymeacoffee.com/livingwaters

In this episode of The Ethics Experts, Nick welcomes Sue Gainor. Sue Gainor is a principal at Grey Point Consulting, LLC, a boutique trade compliance and contracts management consulting practice. Sue provides clients in the aerospace and defense sector with expert advice on the global trade controls regulatory and policy environment; assesses and provides recommendations on corporate compliance, its infrastructure and operations; and engages with key policy makers and regulators to foster business-enabling results.

We welcome Brian Gainor, VP of Innovation of Legends. Brian is a great example of there are more options to work in sports other than the four major professional leagues. He talks about getting his start by volunteering at the University of Florida. We discuss how he decided to get his Masters at Ohio University. Many of you are asking the question, should I go get my Masters. Brian gives you his insight. We discuss what he does every day and where sports is growing. Give a listen and please rate and review! Learn more about your ad choices. Visit podcastchoices.com/adchoices

Show Notes to other shows.Flushing out Toxins.  Lemon/Ginger drinkshttps://www.wholebodydetoxshow.com/111-colonoscopy-vs-colon-hydrotherapy/Show on Juicing https://www.wholebodydetoxshow.com/juicing-for-health-with-john-kohler-of-discountjuicerscom/Lymph Detoxhttps://www.wholebodydetoxshow.com/detox-the-body-in-as-little-as-10-minutes-a-day-using-whole-body-vibration/Learn the benefits of Deep Tissue CleansingWatch www.4NaturalLawsofHealing.comLymphatic Detox. Whole Body Vibration   www.Healthvibrate.comListen to Dr. Gainor explain Whole body Vibrationhttps://www.wholebodydetoxshow.com/detox-the-body-in-as-little-as-10-minutes-a-day-using-whole-body-vibration/Benefits of Raw HoneySingle File Structure Water Bottles available at the office Protecting yourself from EMF's from Cell towers and Cellphones and Wifihttps://www.wholebodydetoxshow.com/102-how-to-protect-your-body-and-home-from-the-damaging-effects-of-electromagnetic-radiation-from-cell-phones-wifi-and-bluetooth-with-wellness-expert-ming-lovejoy/Toxic Chemicals Glyphosatehttps://www.wholebodydetoxshow.com/dr-don-huber-part1/www.facebook.com/livingwaterswellnesshttps://www.wholebodydetoxshow.com/dr-don-huber-part-2/https://www.instagram.com/livingwaterswellnesshttps://www.rumble.com/livingwaterswellnesscenterhttps://www.bitchute.com/livingwaterswellnessSupport the showVisit our website:www.LivingWatersCleanse.com Follow us on our socials:Facebook: www.facebook.com/livingwaterswellnessInstagram: www.instagram.com/livingwaterswellness YouTube: www.Youtube.com/livingwaterswellnesscenterStem Cell Activation Patches:www.StemCellPatch.netSupplements www.Bitchchute.com/livingwaterswellnessIf you like this show, support us by buying me a coffee!Buy Me A Coffee: buymeacoffee.com/livingwaters

The best of Gloria Gainor

Featuring perspectives from Dr D Ross Camidge, Dr Justin Gainor, Prof Benjamin Solomon and Prof Solange Peters, including the following topics: •      Evolving Understanding and Management of Non-Small Cell Lung Cancer (NSCLC) with Targeted Mutations (0:00) •      Adjuvant Therapy for Patients with NSCLC with Targetable Mutations (11:17) •      Family Planning for Patients with Cancer (23:50) •      Optimal Identification of ALK-Positive Metastatic NSCLC — Dr Camidge (30:33) •      Selection of First-Line Treatment for ALK-Positive NSCLC — Dr Gainor (49:22) •      Sequencing and Selection of Therapy for Relapsed/Refractory ALK-Positive NSCLC — Prof Peters (1:23:33) •      Managing Side Effects of ALK Tyrosine Kinase Inhibitors (TKIs) — Prof Solomon (1:39:14) •      Case: A woman in her early 40s with Stage IIIB ALK-positive NSCLC who received alectinib for more than 4 years — Dr Gainor (1:59:37) •      Case: A woman in her mid 50s who remains in complete response with lorlatinib after 4 years — Prof Solomon (2:03:52) •      Case: A woman in her early 60s with Stage IV NSCLC with ALK translocation who received lorlatinib followed by alectinib — Prof Peters (2:10:18) •      Case: A woman in her late 60s with ALK-positive NSCLC who continues to receive brigatinib after discontinuation of alectinib due to concerns of drug-induced pneumonitis — Dr Camidge (2:15:44) •      Case: A woman in her late 40s with NSCLC with an ALK fusion who received multiple ALK TKIs — Dr Gainor (2:21:11) •      Case: A man in his early 30s with ALK-positive NSCLC and brain metastases who continues to receive lorlatinib after 6 years — Prof Solomon (2:26:33) CME information and select publications

Dr Justin Gainor from Massachusetts General Hospital in Boston, Massachusetts, discusses recent therapeutic advances in non-small cell lung cancer with RET fusions. CME information and select publications here (http://www.researchtopractice.com/OncologyTodayRETNSCLC22).

Doug talks to Dan Gainor, prominent media critic in America. Restoration PAC is a non-partisan political action committee that sponsors political activities advocating for policy changes and/or the election or defeat of candidates on the basis of time-tested conservative principles. Visit our website: https://restorationofamerica.com/ Facebook: https://www.facebook.com/restorationamerica Twitter: https://twitter.com/Restorationroa Instagram: https://instagram.com/restorationpac/ GETTR: https://gettr.com/user/restorationpac

Dan Gainor, Vice President of Free Speech America and Business at the Media Research Center, related comments about the sale of Twitter to Elon Musk and its potential implications. You can find out more at mrc.org or newsbusters.org.

Dan Gainor, Vice President of Free Speech America and Business at the Media Research Center, related comments about the sale of Twitter to Elon Musk and its potential implications. You can find out more at mrc.org or newsbusters.org.

In today's episode, Breeanne Carter talks with Drew Gainor, Managing Director & Wealth Management Advisor at Northwestern Mutual. Drew shares how he started out his career in finance, what resume and interview best practices to keep in mind, and how company culture and finding the right fit, really does matter. Listen to learn about the company culture at Northwestern Mutual, what your future could look like working there, how to get started in the finance industry, and more! Drew is an alumnus of UCA's class of 2010, having earned his Bachelor of Business Administration degree in Finance. He and his wife, Lauren, love to give back by staying philanthropically involved. Drew also has 2 boys, Grayson & Davis. Would you like to contact Drew? See how below. LinkedIn: https://www.linkedin.com/in/dgainor/ Northwestern Mutual: https://www.northwesternmutual.com/ Get In Touch Through Website: https://www.northwesternmutual.com/financial/advisor/drew-gainor/

On this episode, we are at Beansnappers, the former Gainors Tavern in Mackville Wisconsin talking with the entertainers and staff about their experiences with the paranormal at Beansnappers as well as in their personal lives. Barnaby and Keg get into an in depth review of some of the activity that has happened since the last update as well. CAPS Website https://www.wisconsincaps.com/ Find and support us on Patreon: https://www.patreon.com/Wisconsincaps YouTube Channel: https://www.youtube.com/c/WisconsinCAPS/ Pick up a book for Ma to review: https://www.amazon.com/hz/wishlist/ls/7VOJMTYA3316 Beansnappers Facebook Page https://www.facebook.com/Beansnappers920/ Paranormal Tours https://www.wisconsincaps.com/public-events/beansnappers-tours/ --- This episode is sponsored by · Anchor: The easiest way to make a podcast. https://anchor.fm/app

Laura Gainor joins to add to the discussion around Pickleball and how it's exploding across communities in addition to the professional side of the sport. For a limited time during 2022, use the code “LIFO” for 15% off one-time packs on sujajuice.com. --- Send in a voice message: https://anchor.fm/lifeinthefrontoffice/message

An Update with Pine City Community Development Director Mike Gainor --- Send in a voice message: https://anchor.fm/wcmp-news/message

Laura Vossberg Gainor is a sports marketer who was introduced to Pickleball and fell in love with it. And also saw many opportunities with the fastest growing sport in the US - and is focusing on them! 

Dan Gainor, Vice-President of Free Speech America, which is an arm of the Media Research Center, discussed the change in leadership at Twitter, in which co-founder Jack Dorsey stepped aside from his position as head of the platform.  You can find out more at mrc.org or newsbusters.org, as well as censortrack.org.

#31 Pickleball it's exploding everywhere. And it's not hard to understand why. It's fun, easy to pick up, and people of all ages can play it. Literally, just about any age!   But what about the marketing pickleball? Even though many people are playing – it's tiny compared to so many other sports. Well on this pod we have ourselves a sit down with Laura Gainor and get into the marketing of the fastest growing sport in America.   Laura is the founder of Vossberg Gainor a marketing agency that focuses on driving awareness for brands and organizations involved in the sport of pickleball. This was so much fun. Laura is a great brand ambassador for the sport. Not only that, but she is also a great example of how to turn your passion into your career.    Enjoy the podcast!   Reach out to Laura on LinkedIn: https://www.linkedin.com/in/lauragainor/   ✅ Connect with Kurt at: Kurtl@celticinc.com ✅ Connect with Pat at: pmcgovern@ascedia.com ✅ Connect with Brian at: BrianM@celticinc.com  

Past Highlights: GMR Marketing and NFL. Expertise: Fan engagement, sponsorship and business strategy. Recorded August 2021. Here is the link to his public profile: https://www.linkedin.com/in/briangainor/

A Conversation with Pine City's Community Development Coordinator Mike Gainor (11.08.21) --- Send in a voice message: https://anchor.fm/wcmp-news/message

Today's episode kicks off our caregiving series, and we're starting with a hard but incredibly important conversation. Pediatrician Lauren Gainor and Neonatal ICU Practitioner Sarah Williamson join me to discuss an overview of the hospital system, preventative childcare, and how to cope with the stress and helplessness if you find yourself in the hospital with your child. Check out the show notes: theinspirationlab.co/post/episode-14 Hospital Packing List & Tips: theinspirationlab.co/post/hospital-packing-list-tips Grab your ticket to the conference: theinspirationlab.co/conference21 Follow us @theinspirationlab and let us know your biggest takeaway from this conversation! © 2021 The Inspiration Lab® Podcast

On today's episode, meet Dr. Justin Gainor. Dr. Gainor is the Director of the Center for Thoracic Cancers at the Massachusetts General Hospital. He is also Director of Targeted Immunotherapy in the Henri and Belinda Termeer Center for Targeted Therapies. Justin received his medical degree from Harvard Medical School, did his Residency at Massachusetts General Hospital and his Fellowship at Brigham and Women's Hospital. His major research interests have centered around two themes: targeted therapy and immunotherapy. He's also an advocate for patients and supporter of The White Ribbon Project.

Dan Gainor from the Media Research Council talks about Facbook upholding President Trumps ban.

MedStar’s Matt Zavadsky and NASEMSO’s Dia Gainor discuss traffic incident management and EMS’s role in multi-agency response after 133 vehicle pileup.

Dr Justin Gainor from the Massachusetts General Hospital in Boston discusses emerging targets in non-small cell lung cancer. CME and select publications here (http://www.researchtopractice.com/OncologyTodayNewTargetsNSCLC21).

Dr. Ian Gainor from T-Zone Whole Body Vibration shares the many ways of using Whole Body Vibration to Detox, Build Bone and Muscle, and increase flexibility in the body. Dr. Gainor shares his many years of experience helping people to restore motion in the body using Whole Body Vibration.  Support the show (http://www.livingwaterscleanse.com)

Listen to our episode on Cartilage Restoration as Dr. Nuelle  gives us an excellent overview!  www.naileditortho.com/cartilage Dr. Nuelle is a board certified orthopaedic surgeon, fellowship trained in sports medicine. He obtained his undergraduate degree from the University of Notre Dame, where he graduated with honors and was inducted into the Alpha Epsilon Delta Honor Society. He then moved to Chicago, where he earned his medical doctorate and graduated with honors from the Loyola University Stritch School of Medicine. He completed his Orthopaedic Surgery residency at the University of Missouri and was fortunate to receive many awards, including the Allen Menard leadership award, the Barry J. Gainor resident award in education, and the Missouri Orthopaedic Institute outstanding Orthopaedic resident award. During his residency, Dr. Nuelle gained the skills necessary to treat a vast array of orthopaedic injuries and patients of any age, but he discovered a special interest in treating athletic injuries. He completed a Fellowship in Sports Medicine at the University of Missouri, where he furthered his knowledge of arthroscopic surgical techniques for the shoulder, elbow, hip, knee, and ankle as well as partial knee replacements. He also served as a team physician for University of Missouri Athletics.   Goal of episode: To develop a baseline knowledge on cartilage defects We cover: Microfracture Osteochondral allografts vs autografts MACI v ACI DeNovo +more              

Biomarker Assessment and Targeted Treatment of Nonsquamous Non-Small Cell Lung Cancer (NSCLC) — Slide Presentation 4: Incidence and Management of Metastatic NSCLC with a RET Rearrangement — Dr Gainor. CME information and select publications

A Roundtable Discussion Featuring Justin F Gainor, MD, Matthew Gubens, MD, MS, Geoffrey R Oxnard, MD, Heather Wakelee, MD, Isaac Levy, MD and Estelamari Rodriguez, MD, MPH moderated by Neil Love, MD. Produced by Research To Practice.

Part 2 with Brian Gainor takes a total dive into how 4FRONT is helping organizations through the COVID-19 Crisis. We talk about trends that may change sports in the future and how to adapt and take advantage.

Part 1 with Brian Gainor, VP Innovation at 4FRONT, dives into his career path and the lessons he has learned from it that can apply to others

Summary: 1. Staging - know where to look (based on primary site but also pathology) 2. Restaging - know what to expect (based on type of treatment - XRT, chemo, immunotherapy) 3. Big picture - same, better, worse; critical lesions that may require treatment (impending fractures, spinal cord involvement) 4. Chose words carefully - careful about using “progression” unless you are going to calculate that this meets RECIST criteria - consider using “increased tumor burden” instead Host: Christopher Cerniglia, DO, ME, FAOCR. Associate Professor of Radiology, Division of Musculoskeletal Imaging & Intervention, UMMS Dept of Radiology. Guest: Lacey J McIntosh DO, MPH. Assistant Professor of Radiology, Divisions of Abdominal Imaging and Nuclear Medicine, UMMS Dept of Radiology. Resources: Wang, G. X., Kurra, V., Gainor, J. F., Sullivan, R. J., Flaherty, K. T., Lee, S. I., & Fintelmann, F. J. (2017). Immune checkpoint inhibitor cancer therapy: spectrum of imaging findings. Radiographics, 37(7), 2132-2144.

Today we’ve got a special episode with Canadian space exploration historian Chris Gainor. This past week Gainor was a guest on the Future in Space Operations teleconference. The topic of Gainor's talk was Hubble Space Telescope’s Contributions to Servicing Spacecraft On Orbit. For anyone interested in on-orbit spacecraft servicing, Gainor's research which will soon be published as a NASA Special Publication book and should be essential reading. The Hubble Space Telescope wasn’t designed to be serviced, and yet when critical problems arose, new techniques and plans were conceived which led to multiple servicing missions. The hard lessons learned in the servicing of Hubble shouldn’t be forgotten. Listen in.

Summary: 1. How functional imaging is different from anatomic imaging 2. Different tracers - FDG, NAF, DOTATATE, AXUMIN, PSMA 3. Limitations (size, lack of contrast in some places) 4. Pitfalls - know expected physiologic uptake and other processes that cause uptake 5. Future of PET - exciting implications for therapies Host: Christopher Cerniglia, DO, ME, FAOCR. Associate Professor of Radiology, Division of Musculoskeletal Imaging & Intervention, UMMS Dept of Radiology. Guest: Lacey J McIntosh DO, MPH. Assistant Professor of Radiology, Divisions of Abdominal Imaging and Nuclear Medicine, UMMS Dept of Radiology. Resources: 1. Kapoor, V., McCook, B. M., & Torok, F. S. (2004). An introduction to PET-CT imaging. Radiographics, 24(2), 523-543.. 2. Bar-Shalom, R., Valdivia, A. Y., & Blaufox, M. D. (2000, July). PET imaging in oncology. In Seminars in nuclear medicine (Vol. 30, No. 3, pp. 150-185). WB Saunders. 3. Wallitt, K., Yusuf, S., Soneji, N., Khan, S. R., Win, Z., & Barwick, T. D. (2018). PET/CT in Oncologic Imaging of Nodal Disease: Pearls and Pitfalls: RadioGraphics Fundamentals| Online Presentation. RadioGraphics, 38(2), 564-565. 4. Wang, G. X., Kurra, V., Gainor, J. F., Sullivan, R. J., Flaherty, K. T., Lee, S. I., & Fintelmann, F. J. (2017). Immune checkpoint inhibitor cancer therapy: spectrum of imaging findings. Radiographics, 37(7), 2132-2144.

TODAYS GUESTS AND TOPICS... Polluck, Cooper, Houck, Gainor, Ludwig, Gong, Whitaker, Robinson

Join us for a conversation with Glenn Gainor, Head of Physical Production at Sony Pictures Screen Gems and Head of Sony Innovation Studios. This episode explores embracing technology as an empowerment tool and how filmmakers can have their stories heard by millions, through the use of emerging technologies. Glenn speaks about passion for short film, new innovations in technology, collaborations with camera engineers, the use of neuralised technology to create virtual sets and providing opportunity for filmmakers to use technology to inspire change. This episode is hosted by Screenwest Talent Development Executive, Eva Di Blasio. This is the final series of Cinefest Sessions recorded at Busselton’s City Council Chambers during CinefestOZ Film Festival 2019.   In Conversation is a Screenwest production. Screenwest is a non-profit organisation dedicated to providing strategic leadership and assistance to the film and television industry in Western Australia. Find out more at www.screenwest.com.au and www.filminwesternaustralia.com.au. Follow us on Facebook, Twitter, Instagram, LinkedIn and subscribe to our newsletter to stay up to date with Screenwest.

If you've ever wondered what the heck a float spa is, we have all the answers you need in this episode. Elana Gainor (@SageFloatSpa), the founder/owner of Sage Float Spa in Capitola, CA chats with Brooke and Jeanna about the benefits of float spas, how she integrates CBD in the sessions, and why there are absolutely no happy endings at Sage. So please don't ask. For more info on Sage Float Spa: https://www.sagefloatspa.com/ Send us emails at: betweenthereps@gmail.com  For more Brooke on Insta: @brookeence  For more Jeanna on Insta: @jeanna_cianciarulo Learn more about your ad choices. Visit megaphone.fm/adchoices

When David and Dawn Gainor wanted to start a family, it was more challenging than they expected.

Bob Merritt, Randy Newman, Dan Gainor, David Curry, Luann Dunnuck

Bob Merritt, Randy Newman, Dan Gainor, David Curry, Luann Dunnuck

Go online to PeerView.com/FQK860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. As a result of intense research efforts, the foundational understanding of the interplay between cancer and immunity and how to harness it for therapeutic benefit is deepening. As the evidence base grows exponentially, the treatment landscape is becoming more complicated, highlighting the need for precision approaches to maximize the potential of immuno-oncology. In this activity, based on a recent live symposium held in San Francisco, CA, experts in immuno-oncology explore the latest evidence and data on the present and future of cancer immunotherapies and biomarkers, debate critical issues, and share practical guidance that you can use in the care of your patients with cancer. Upon completion of this activity, participants will be able to: Review the most up-to-date evidence and mechanistic understanding supporting the use of current and emerging cancer immunotherapies, including single-agent and combination approaches, across a spectrum of different malignancies, Evaluate the latest evidence on the role and use of established, novel, and emerging cancer immunotherapy biomarkers (eg, PD-L1, MSI/MMR, TMB, TILs, LAG-3, composite biomarkers, et cetera), Integrate into practice up-to-date cancer immunotherapy biomarker testing approaches and immune-based therapies/combinations according to the latest evidence, recommendations, and principles of precision immuno-oncology.

Go online to PeerView.com/FQK860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. As a result of intense research efforts, the foundational understanding of the interplay between cancer and immunity and how to harness it for therapeutic benefit is deepening. As the evidence base grows exponentially, the treatment landscape is becoming more complicated, highlighting the need for precision approaches to maximize the potential of immuno-oncology. In this activity, based on a recent live symposium held in San Francisco, CA, experts in immuno-oncology explore the latest evidence and data on the present and future of cancer immunotherapies and biomarkers, debate critical issues, and share practical guidance that you can use in the care of your patients with cancer. Upon completion of this activity, participants will be able to: Review the most up-to-date evidence and mechanistic understanding supporting the use of current and emerging cancer immunotherapies, including single-agent and combination approaches, across a spectrum of different malignancies, Evaluate the latest evidence on the role and use of established, novel, and emerging cancer immunotherapy biomarkers (eg, PD-L1, MSI/MMR, TMB, TILs, LAG-3, composite biomarkers, et cetera), Integrate into practice up-to-date cancer immunotherapy biomarker testing approaches and immune-based therapies/combinations according to the latest evidence, recommendations, and principles of precision immuno-oncology.

Go online to PeerView.com/FQK860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. As a result of intense research efforts, the foundational understanding of the interplay between cancer and immunity and how to harness it for therapeutic benefit is deepening. As the evidence base grows exponentially, the treatment landscape is becoming more complicated, highlighting the need for precision approaches to maximize the potential of immuno-oncology. In this activity, based on a recent live symposium held in San Francisco, CA, experts in immuno-oncology explore the latest evidence and data on the present and future of cancer immunotherapies and biomarkers, debate critical issues, and share practical guidance that you can use in the care of your patients with cancer. Upon completion of this activity, participants will be able to: Review the most up-to-date evidence and mechanistic understanding supporting the use of current and emerging cancer immunotherapies, including single-agent and combination approaches, across a spectrum of different malignancies, Evaluate the latest evidence on the role and use of established, novel, and emerging cancer immunotherapy biomarkers (eg, PD-L1, MSI/MMR, TMB, TILs, LAG-3, composite biomarkers, et cetera), Integrate into practice up-to-date cancer immunotherapy biomarker testing approaches and immune-based therapies/combinations according to the latest evidence, recommendations, and principles of precision immuno-oncology.

Go online to PeerView.com/FQK860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. As a result of intense research efforts, the foundational understanding of the interplay between cancer and immunity and how to harness it for therapeutic benefit is deepening. As the evidence base grows exponentially, the treatment landscape is becoming more complicated, highlighting the need for precision approaches to maximize the potential of immuno-oncology. In this activity, based on a recent live symposium held in San Francisco, CA, experts in immuno-oncology explore the latest evidence and data on the present and future of cancer immunotherapies and biomarkers, debate critical issues, and share practical guidance that you can use in the care of your patients with cancer. Upon completion of this activity, participants will be able to: Review the most up-to-date evidence and mechanistic understanding supporting the use of current and emerging cancer immunotherapies, including single-agent and combination approaches, across a spectrum of different malignancies, Evaluate the latest evidence on the role and use of established, novel, and emerging cancer immunotherapy biomarkers (eg, PD-L1, MSI/MMR, TMB, TILs, LAG-3, composite biomarkers, et cetera), Integrate into practice up-to-date cancer immunotherapy biomarker testing approaches and immune-based therapies/combinations according to the latest evidence, recommendations, and principles of precision immuno-oncology.

Go online to PeerView.com/FQK860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. As a result of intense research efforts, the foundational understanding of the interplay between cancer and immunity and how to harness it for therapeutic benefit is deepening. As the evidence base grows exponentially, the treatment landscape is becoming more complicated, highlighting the need for precision approaches to maximize the potential of immuno-oncology. In this activity, based on a recent live symposium held in San Francisco, CA, experts in immuno-oncology explore the latest evidence and data on the present and future of cancer immunotherapies and biomarkers, debate critical issues, and share practical guidance that you can use in the care of your patients with cancer. Upon completion of this activity, participants will be able to: Review the most up-to-date evidence and mechanistic understanding supporting the use of current and emerging cancer immunotherapies, including single-agent and combination approaches, across a spectrum of different malignancies, Evaluate the latest evidence on the role and use of established, novel, and emerging cancer immunotherapy biomarkers (eg, PD-L1, MSI/MMR, TMB, TILs, LAG-3, composite biomarkers, et cetera), Integrate into practice up-to-date cancer immunotherapy biomarker testing approaches and immune-based therapies/combinations according to the latest evidence, recommendations, and principles of precision immuno-oncology.

Go online to PeerView.com/FQK860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. As a result of intense research efforts, the foundational understanding of the interplay between cancer and immunity and how to harness it for therapeutic benefit is deepening. As the evidence base grows exponentially, the treatment landscape is becoming more complicated, highlighting the need for precision approaches to maximize the potential of immuno-oncology. In this activity, based on a recent live symposium held in San Francisco, CA, experts in immuno-oncology explore the latest evidence and data on the present and future of cancer immunotherapies and biomarkers, debate critical issues, and share practical guidance that you can use in the care of your patients with cancer. Upon completion of this activity, participants will be able to: Review the most up-to-date evidence and mechanistic understanding supporting the use of current and emerging cancer immunotherapies, including single-agent and combination approaches, across a spectrum of different malignancies, Evaluate the latest evidence on the role and use of established, novel, and emerging cancer immunotherapy biomarkers (eg, PD-L1, MSI/MMR, TMB, TILs, LAG-3, composite biomarkers, et cetera), Integrate into practice up-to-date cancer immunotherapy biomarker testing approaches and immune-based therapies/combinations according to the latest evidence, recommendations, and principles of precision immuno-oncology.

Go online to PeerView.com/FQK860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. As a result of intense research efforts, the foundational understanding of the interplay between cancer and immunity and how to harness it for therapeutic benefit is deepening. As the evidence base grows exponentially, the treatment landscape is becoming more complicated, highlighting the need for precision approaches to maximize the potential of immuno-oncology. In this activity, based on a recent live symposium held in San Francisco, CA, experts in immuno-oncology explore the latest evidence and data on the present and future of cancer immunotherapies and biomarkers, debate critical issues, and share practical guidance that you can use in the care of your patients with cancer. Upon completion of this activity, participants will be able to: Review the most up-to-date evidence and mechanistic understanding supporting the use of current and emerging cancer immunotherapies, including single-agent and combination approaches, across a spectrum of different malignancies, Evaluate the latest evidence on the role and use of established, novel, and emerging cancer immunotherapy biomarkers (eg, PD-L1, MSI/MMR, TMB, TILs, LAG-3, composite biomarkers, et cetera), Integrate into practice up-to-date cancer immunotherapy biomarker testing approaches and immune-based therapies/combinations according to the latest evidence, recommendations, and principles of precision immuno-oncology.

Go online to PeerView.com/FQK860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. As a result of intense research efforts, the foundational understanding of the interplay between cancer and immunity and how to harness it for therapeutic benefit is deepening. As the evidence base grows exponentially, the treatment landscape is becoming more complicated, highlighting the need for precision approaches to maximize the potential of immuno-oncology. In this activity, based on a recent live symposium held in San Francisco, CA, experts in immuno-oncology explore the latest evidence and data on the present and future of cancer immunotherapies and biomarkers, debate critical issues, and share practical guidance that you can use in the care of your patients with cancer. Upon completion of this activity, participants will be able to: Review the most up-to-date evidence and mechanistic understanding supporting the use of current and emerging cancer immunotherapies, including single-agent and combination approaches, across a spectrum of different malignancies, Evaluate the latest evidence on the role and use of established, novel, and emerging cancer immunotherapy biomarkers (eg, PD-L1, MSI/MMR, TMB, TILs, LAG-3, composite biomarkers, et cetera), Integrate into practice up-to-date cancer immunotherapy biomarker testing approaches and immune-based therapies/combinations according to the latest evidence, recommendations, and principles of precision immuno-oncology.

Go online to PeerView.com/FQK860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. As a result of intense research efforts, the foundational understanding of the interplay between cancer and immunity and how to harness it for therapeutic benefit is deepening. As the evidence base grows exponentially, the treatment landscape is becoming more complicated, highlighting the need for precision approaches to maximize the potential of immuno-oncology. In this activity, based on a recent live symposium held in San Francisco, CA, experts in immuno-oncology explore the latest evidence and data on the present and future of cancer immunotherapies and biomarkers, debate critical issues, and share practical guidance that you can use in the care of your patients with cancer. Upon completion of this activity, participants will be able to: Review the most up-to-date evidence and mechanistic understanding supporting the use of current and emerging cancer immunotherapies, including single-agent and combination approaches, across a spectrum of different malignancies, Evaluate the latest evidence on the role and use of established, novel, and emerging cancer immunotherapy biomarkers (eg, PD-L1, MSI/MMR, TMB, TILs, LAG-3, composite biomarkers, et cetera), Integrate into practice up-to-date cancer immunotherapy biomarker testing approaches and immune-based therapies/combinations according to the latest evidence, recommendations, and principles of precision immuno-oncology.

Go online to PeerView.com/FQK860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. As a result of intense research efforts, the foundational understanding of the interplay between cancer and immunity and how to harness it for therapeutic benefit is deepening. As the evidence base grows exponentially, the treatment landscape is becoming more complicated, highlighting the need for precision approaches to maximize the potential of immuno-oncology. In this activity, based on a recent live symposium held in San Francisco, CA, experts in immuno-oncology explore the latest evidence and data on the present and future of cancer immunotherapies and biomarkers, debate critical issues, and share practical guidance that you can use in the care of your patients with cancer. Upon completion of this activity, participants will be able to: Review the most up-to-date evidence and mechanistic understanding supporting the use of current and emerging cancer immunotherapies, including single-agent and combination approaches, across a spectrum of different malignancies, Evaluate the latest evidence on the role and use of established, novel, and emerging cancer immunotherapy biomarkers (eg, PD-L1, MSI/MMR, TMB, TILs, LAG-3, composite biomarkers, et cetera), Integrate into practice up-to-date cancer immunotherapy biomarker testing approaches and immune-based therapies/combinations according to the latest evidence, recommendations, and principles of precision immuno-oncology.

Go online to PeerView.com/FQK860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. As a result of intense research efforts, the foundational understanding of the interplay between cancer and immunity and how to harness it for therapeutic benefit is deepening. As the evidence base grows exponentially, the treatment landscape is becoming more complicated, highlighting the need for precision approaches to maximize the potential of immuno-oncology. In this activity, based on a recent live symposium held in San Francisco, CA, experts in immuno-oncology explore the latest evidence and data on the present and future of cancer immunotherapies and biomarkers, debate critical issues, and share practical guidance that you can use in the care of your patients with cancer. Upon completion of this activity, participants will be able to: Review the most up-to-date evidence and mechanistic understanding supporting the use of current and emerging cancer immunotherapies, including single-agent and combination approaches, across a spectrum of different malignancies, Evaluate the latest evidence on the role and use of established, novel, and emerging cancer immunotherapy biomarkers (eg, PD-L1, MSI/MMR, TMB, TILs, LAG-3, composite biomarkers, et cetera), Integrate into practice up-to-date cancer immunotherapy biomarker testing approaches and immune-based therapies/combinations according to the latest evidence, recommendations, and principles of precision immuno-oncology.

Go online to PeerView.com/FQK860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. As a result of intense research efforts, the foundational understanding of the interplay between cancer and immunity and how to harness it for therapeutic benefit is deepening. As the evidence base grows exponentially, the treatment landscape is becoming more complicated, highlighting the need for precision approaches to maximize the potential of immuno-oncology. In this activity, based on a recent live symposium held in San Francisco, CA, experts in immuno-oncology explore the latest evidence and data on the present and future of cancer immunotherapies and biomarkers, debate critical issues, and share practical guidance that you can use in the care of your patients with cancer. Upon completion of this activity, participants will be able to: Review the most up-to-date evidence and mechanistic understanding supporting the use of current and emerging cancer immunotherapies, including single-agent and combination approaches, across a spectrum of different malignancies, Evaluate the latest evidence on the role and use of established, novel, and emerging cancer immunotherapy biomarkers (eg, PD-L1, MSI/MMR, TMB, TILs, LAG-3, composite biomarkers, et cetera), Integrate into practice up-to-date cancer immunotherapy biomarker testing approaches and immune-based therapies/combinations according to the latest evidence, recommendations, and principles of precision immuno-oncology.

Dr. Gainor from Mass General Hospital stops by to chat with Billy and Jenny about all the amazing things MGH is doing to help their patients battle cancer.

Ep. 199: Gabrielle Kazuko Nomura Gainor grew up immersed in Seattle’s arts and cultural scene since birth, and now works in administration for Seattle Opera, as an independent dance artist, and as an activist with the Japanese American Citizens League. She identifies as Asian American, and culturally, as Japanese American; while also fully owning and embracing being of Japanese, Filipino, Spanish and Irish American heritage. As a member of a mixed family, she is married to a white musician and they have a 1-year-old daughter Kiyomi (whom they assume identifies as female and as Mixed Race). Gabrielle’s most recent dance work, “Farewell Shikata ga nai” combines live theater, dance and taiko drumming to tell the story of how her family and community were forcibly removed and incarcerated during World War II. This piece will be touring local Seattle schools in May 2019. Gabrielle is in the very early phases of planning a conference for Mixed Race Asians with the Japanese American Citizens League, which will be focused on anti-racism work, community building, and sharing our mixed stories through art and performance. Gabrielle holds degrees in journalism and dance from Western Washington University. For more on host, Alex Barnett, please check out his website: www.alexbarnettcomic.com or visit him on Facebook (www.facebook.com/alexbarnettcomic) or on Twitter at @barnettcomic To subscribe to the Multiracial Family Man, please click here: MULTIRACIAL FAMILY MAN PODCAST Huge shout out to our "Super-Duper Supporters" Elizabeth A. Atkins and Catherine Atkins Greenspan of Two Sisters Writing and Publishing Intro and Outro Music is Funkorama by Kevin MacLeod (incompetech.com) Licensed under Creative Commons - By Attribution 3.0 http://creativecommons.org/licenses/by/3.0/

Proceedings from video interviews with Drs David R Spigel and Justin F Gainor on optimal strategies and emerging concepts in the management of lung cancer. | For more information, visit: http://www.researchtopractice.com/LCU318/Video

Elizabeth Warren Speaks With A Forked Tongue... Today's topics include: ...that may be the bottom line regarding Warren's claims to be part Native American. She finally had a DNA test done to show what her real heritage is - and let's just say based on the results, we all probably have just as much of a tie to Native American heritage as Warren does; next up, some football talk. Why there is no love lost with Le'Veon Bell. The Steelers, and James Conner especially, are doing just fine without Bell...; also, why is Hillary Clinton still doing interviews? She is out there still defending Bill, saying Monica Lewinsky was an "adult" at the time and Bill did not abuse his power as a President in that situation; and finally, Dan Gainor (Vice President of Business and Culture at the Media Research Center) joins the show to talk about a leaked document from Google, which shows the people at Google like the "European" version of "free speech" better. Gainor explains what this means, and why it's troubling. See omnystudio.com/listener for privacy information.

Conversations with Oncology Investigators. Bridging the Gap between Research and Patient Care. Interview with Justin F Gainor, MD conducted by Neil Love, MD. Produced by Research To Practice.

Listen to the story here and see the accompanying photos at MAEKAN.com for the best experience. When the information age nostalgically looked back toward traditional craftsmanship for inspiration, we ended up with hand-stitched leather cases for our tablets and artisan wooden styluses to go with it. But for something we use literally every day, why haven’t we been handcrafting sneakers? This is just what bespoke luxury sneaker label No.One does, a dozen and a half pairs at a time. Good things take time, and founder Mark Gainor doesn’t seem to mind. Script and Narration by Nate Kan Audio by Elphick Wo Photos by Eugene --- Support this podcast: https://anchor.fm/maekan/support

From building the only not-for-profit, all volunteer advertising agency in the nation to starring as a guest in magazines like PR Daily, Milwaukee Business Journal, and more Laura Gainor has used networking every step of the way

Simon interviews VP of Business & Culture at the Media Research Center, Dan Gainor!

Doug interviews Craig Cogil, Dan Gainor, & Sarah Nusser

A quick hello, and a little blast from the past for your amusement... www.kgainor.com Google +: https://plus.google.com/u/1/100547187418444691782/posts (K. Gainor) www.twitter.com/kgainor paladincorpsnovel@gmail.com Theme Music By Anne Garner: www.annegarner.com Artwork by Scott E. Pond: www.scottepond.com

... Yeah... That... Enjoy! :-P www.kgainor.com Google +: https://plus.google.com/u/1/100547187418444691782/posts (K. Gainor) www.twitter.com/kgainor paladincorpsnovel@gmail.com Theme Music By Anne Garner: www.annegarner.com Artwork by Scott E. Pond: www.scottepond.com

A quick Mea Culpa-ish InfoBurst, with a bonus Paul E. Cooley style/inspired essay. www.kgainor.com Google +: https://plus.google.com/u/1/100547187418444691782/posts (K. Gainor) www.twitter.com/kgainor paladincorpsnovel@gmail.com Theme Music By Anne Garner: www.annegarner.com Artwork by Scott E. Pond: www.scottepond.com

A semi-brief update on what is happening in this neck o' the woods... Listen at your own discretion., ;-) www.kgainor.com Google +: https://plus.google.com/u/1/100547187418444691782/posts (K. Gainor) www.twitter.com/kgainor paladincorpsnovel@gmail.com Theme Music By Anne Garner: www.annegarner.com Artwork by Scott E. Pond: www.scottepond.com

Paladin Corps: Book 1 - Episode 2 Kevin and Derek race to the armed robbery call, and find more than they ever expected... NSA agent Christopher Duncan witnesses a truly unbelievable sight... www.kgainor.com Google Plus: K. Gainor (Author Page) www.twitter.com/kgainor paladincorpsnovel@gmail.com Theme Music By Anne Garner: www.annegarner.com Story Edited by Gabrielle Birchak: www.gabriellebirchak.com Artwork by Scott E. Pond: www.scottepond.com Podcast Audio edited by Steve O.: www.twitter.com/trstno1192

In the debut episode (yes, I'm calling this the real debut episode.... No, you can't make me claim the other one.... I refuse! :-P ) of Paladin Corps: Book 1, we meet Jackson, MI police officer Kevin Lahzur, and get a glimpse into his past, and his struggles. www.kgainor.com www.twitter.com/kgainor Theme music, Home, Outbound,  provided by Anne Garner: www.annegarner.com